biote Corp.
corporate_fare Company Profile
biote Corp. (NASDAQ:BTMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for BTMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-12, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for BTMD spans 4, 10-Q, 8-K, 8-K/A.
Recent high-impact activity:
- Executive Chairman Marc Beer Buys $202K of Biote Stock
- Biote Q2 Loss Deepens, Material Weakness Lingers, and CEO Transition Concludes
- Biote Swings to Q2 Loss, Slashes Full-Year Outlook as Recall Fallout Persists
- Biote Corp. Finalizes Interim CEO Compensation with Significant Equity Grant
- Biote Corp. Announces CEO Resignation, Appoints Interim CEO and Executive Chairman, Reaffirms 2026 Guidance
Financial Snapshot
Short Interest & Short Volume
5.18 days to coverFINRA reported short interest of 1,280,901 shares in BTMD as of the September 15, 2026 settlement, a 8.2% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On October 2, 2026, 63.6% of BTMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.